{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:16:23Z","timestamp":1795112183813,"version":"4.10.3"},"reference-count":249,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Qatar Research, Development & Innovation (QRDI) National Priorities Research Program","award":["NPRP13S-0126-200173]"],"award-info":[{"award-number":["NPRP13S-0126-200173]"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"published-print":{"date-parts":[[2025,9,2]]},"DOI":"10.1080\/17425247.2025.2516668","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:45:11Z","timestamp":1749210311000},"page":"1275-1301","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Tyrosine kinase inhibitors and their promising role in treating diabetic retinopathy and other retinal vascular diseases: overview of their routes of administration, pharmacokinetics, formulations, and drug delivery applications"],"prefix":"10.1080","volume":"22","author":[{"given":"Hana","family":"Kadavil","sequence":"first","affiliation":[{"name":"Qatar University","place":["Doha, Qatar"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandi","family":"Ali Adib","sequence":"additional","affiliation":[{"name":"Qatar University","place":["Doha, Qatar"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia","family":"Marei","sequence":"additional","affiliation":[{"name":"Qatar University","place":["Doha, Qatar"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noora H.","family":"Al-Qahtani","sequence":"additional","affiliation":[{"name":"Qatar University","place":["Doha, Qatar"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[{"name":"Kingston University London","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"Al-Kinani","sequence":"additional","affiliation":[{"name":"Kingston University London","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0355-7499","authenticated-orcid":false,"given":"Raid G.","family":"Alany","sequence":"additional","affiliation":[{"name":"Kingston University London","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8191-4415","authenticated-orcid":false,"given":"Husam M.","family":"Younes","sequence":"additional","affiliation":[{"name":"Qatar University","place":["Doha, Qatar"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"e_1_3_5_3_1","volume-title":"Diabetes Atlas","author":"Magliano DJ","year":"2025","unstructured":"Magliano DJ, Boyko EJ. Diabetes Atlas. 11th ed. Brussels, Belgium: International Diabetes Federation; 2025. https:\/\/diabetesatlas.org\/resources\/idf-diabetes-atlas-2025\/","edition":"11"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.15.47"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.04.027"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2021.02.009"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.26074"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313053"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1993.66"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4435-8"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2015.08.001"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2017.04.003"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.355743"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/08820530902800330"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2010.02010.x"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051413"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta25380"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000849"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-021-01026-5"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)01372-1"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(00)00501-8"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2022.11.008"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.04.007"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/0300060518816884"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e32831d7f3a"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062655"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.02.003"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.07.068"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1077669"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1049\/iet-nbt.2019.0002"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1415846"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2020.1801631"},{"key":"e_1_3_5_33_1","article-title":"A review of tyrosine kinase inhibitors","author":"Reeda Bou Said TX","year":"2024","unstructured":"Reeda Bou Said TX, Bakri SJ. A review of tyrosine kinase inhibitors. Rev Ophthalmol. 2024 Sep 10. https:\/\/www.reviewofophthalmology.com\/article\/a-review-of-tyrosine-kinase-inhibitors","journal-title":"Rev Ophthalmol"},{"issue":"2024","key":"e_1_3_5_34_1","first-page":"14","article-title":"Tyrosine kinase inhibitors for wet AMD and Diabetic retinopathy","volume":"21","author":"Nikhil Das KET","year":"2024","unstructured":"Nikhil Das KET. Tyrosine kinase inhibitors for wet AMD and Diabetic retinopathy. Retinal Physician. 2024;21(April 2024):14\u201317.","journal-title":"Retinal Physician"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2016.10.015"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2025.2460671"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.8.1.12"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.10.036"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.7.4.21"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115535"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2017.05.009"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124018"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01992-2"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-90471-1.00002-5"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.4c00725"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02516-9"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2014.10.006"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/02813432.2024.2329215"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061816"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19040942"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4435-8"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2015.08.001"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2010.06.033"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207528"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2007.S84"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.9.2653"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i3.489"},{"issue":"1","key":"e_1_3_5_58_1","first-page":"106594","article-title":"Animal models of diabetic retinopathy: summary and comparison","volume":"2013","author":"Lai AKW","year":"2013","unstructured":"Lai AKW, Lo ACY. Animal models of diabetic retinopathy: summary and comparison. J Diabetes Res. 2013;2013(1):106594.","journal-title":"J Diabetes Res"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1177\/1947601911423031"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106026"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.05.009"},{"issue":"8","key":"e_1_3_5_62_1","first-page":"218","article-title":"Phase 1 study of an intravitreal axitinib hydrogel-based implant for the treatment of neovascular age-related macular degeneration (nAMD)","volume":"62","author":"Wong JG","year":"2021","unstructured":"Wong JG, Chang A, Guymer RH, et al. Phase 1 study of an intravitreal axitinib hydrogel-based implant for the treatment of neovascular age-related macular degeneration (nAMD). Invest Ophthalmol Visual Sci. 2021;62(8):218\u2013218.","journal-title":"Invest Ophthalmol Visual Sci"},{"issue":"8","key":"e_1_3_5_63_1","first-page":"447","article-title":"Toward a non-invasive solution of wet AMD: sunitinib, pazopanib, and axitinib eyedrops versus intraocular injection of Aflibercept","volume":"62","author":"Kim K-H","year":"2021","unstructured":"Kim K-H, Oh JY, Cho D, et al. Toward a non-invasive solution of wet AMD: sunitinib, pazopanib, and axitinib eyedrops versus intraocular injection of Aflibercept. Invest Ophthalmol Visual Sci. 2021;62(8):447\u2013447.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-013-0068-3"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2022.01.001"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-023-02610-z"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1039\/D0TB00874E"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2023.2247987"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.3390\/vision3030041"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2014.09.011"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(92)90483-2"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/87904"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.01.021"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17634"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.15101"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0793-1"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-8719(00)00107-6"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15041149"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.08.036"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010134"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17040447"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612822666151216145900"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2021.100125"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1159\/000055638"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01469-6"},{"key":"e_1_3_5_86_1","unstructured":"National Center for Biotechnology Information. PubChem compound summary for CID 6450551 axitinib. [cited 2025 Apr 29]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Axitinib. [Internet]."},{"key":"e_1_3_5_87_1","unstructured":"DrugBank. Axitinib (DB06626) - [Internet]. 2025. Available from: https:\/\/go.drugbank.com\/drugs\/DB06626"},{"key":"e_1_3_5_88_1","unstructured":"Pfizer Medical Information. INLYTA (axitinib). 2025. Available from: https:\/\/www.pfizermedicalinformation.com\/inlyta\/description [Internet]."},{"key":"e_1_3_5_89_1","volume-title":"Cyclodextrin nanoparticles for targeted ocular drug delivery of kinase inhibitors","author":"Praphanwittaya P","year":"2020","unstructured":"Praphanwittaya P. Cyclodextrin nanoparticles for targeted ocular drug delivery of kinase inhibitors. Reykjav\u00edk (Iceland): University of Iceland; 2020."},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101462"},{"key":"e_1_3_5_91_1","volume-title":"PubChem compound summary for CID 9811611, 3-((4-bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carboxamide","author":"PubChem, National Library of Medicine NCfBI","year":"2004","unstructured":"PubChem, National Library of Medicine NCfBI. PubChem compound summary for CID 9811611, 3-((4-bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carboxamide. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004."},{"key":"e_1_3_5_92_1","volume-title":"PubChem compound summary for CID 59394698, Acrizanib","author":"PubChem, National Library of Medicine NCfBI","year":"2004","unstructured":"PubChem, National Library of Medicine NCfBI. PubChem compound summary for CID 59394698, Acrizanib. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004."},{"key":"e_1_3_5_93_1","unstructured":"National Center for Biotechnology Information. \u201cPubChem compound summary for CID 11315474. Rivoceranib\u201d: PubChem; [cited 2025 Apr 29]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Rivoceranib"},{"key":"e_1_3_5_94_1","volume-title":"Drug label for Sunitinib (NDA 021938)","author":"FDA","year":"2011","unstructured":"FDA. Drug label for Sunitinib (NDA 021938). Silver Spring (MD): Food and Drug Administration; 2011."},{"key":"e_1_3_5_95_1","unstructured":"National Center for Biotechnology Information. \u201cPubChem compound summary for CID 5329102 Sunitinib\u201d PubChem. [cited 2025 Apr 29]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Sunitinib"},{"key":"e_1_3_5_96_1","unstructured":"Vorolanib. National center for Biotechnology Information. \u201cPubChem compound summary for CID 59215954 Vorolanib\u201d PubChem. [cited 2025 Apr 30]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Vorolanib"},{"key":"e_1_3_5_97_1","unstructured":"Nintedanib. National center for Biotechnology Information. \u201cPubChem compound summary for CID 135423438 Nintedanib\u201d PubChem. [cited 2025 Apr 30]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Nintedanib"},{"key":"e_1_3_5_98_1","unstructured":"Sorafenib. National center for Biotechnology Information. \u201cPubChem compound summary for CID 216239 Sorafenib\u201d PubChem. [cited 2025 Apr 30]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Sorafenib"},{"key":"e_1_3_5_99_1","doi-asserted-by":"crossref","unstructured":"Abdelgalil AA Alkahtani HM Al-Jenoobi FS. Profiles drug subst excip relat methodol. Sorafenib. 2019;44:239\u2013266.","DOI":"10.1016\/bs.podrm.2018.11.003"},{"key":"e_1_3_5_100_1","unstructured":"Imatinib. National center for Biotechnology Information. \u201cPubChem compound summary for CID 5291 Imatinib\u201d PubChem. [cited 2025 Apr 30]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Imatinib"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.10.7.19"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0488-y"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01731"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2018.10.032"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2016.02.010"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1415846"},{"key":"e_1_3_5_107_1","unstructured":"Bottger M Von Degenfeld G Freundlieb J et al. Inventors.Topical ophthalmological pharmaceutical composition containing cediranib patent. International Patent Application Publication WO2013188279A. 2015. https:\/\/patents.google.com\/patent\/WO2013188279A1\/en"},{"key":"e_1_3_5_108_1","article-title":"Nika Bagheri What\u2019s in the works for wet AMD","author":"Meghana Kalavar DP","year":"2022","unstructured":"Meghana Kalavar DP. Nika Bagheri What\u2019s in the works for wet AMD. Retina Today. 2022 Nov\/Dec. https:\/\/retinatoday.com\/articles\/2022-nov-dec\/whats-in-the-works-for-wet-amd","journal-title":"Retina Today"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27165089"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.1571"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2024.100527"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-017-0826-x"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14340-x"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106530"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091875"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2012.734642"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000179"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13794"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm501562a"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S224044"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00766-0"},{"key":"e_1_3_5_122_1","volume-title":"Compositions and methods for treating pterygium","author":"Ni J","year":"2018","unstructured":"Ni J. Compositions and methods for treating pterygium. United states published patent US9987223B2. Alexandria (Virginia): United States Patent and Trademark Office (USPTO); 2018. https:\/\/patents.google.com\/patent\/WO2016200688A1\/en"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2022.02.009"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.3390\/gels8020082"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212368"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14050998"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1533\/9781908818317.1"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1007\/164_2016_32"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10010028"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2011.0124"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.021121"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering9010041"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1080\/03602532.2024.2368247"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121105"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389200043335342"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.3109\/03602532.2014.921190"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2006.07.027"},{"issue":"3","key":"e_1_3_5_138_1","first-page":"171","article-title":"Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations","volume":"63","author":"Loftsson T","year":"2008","unstructured":"Loftsson T, Sigurdsson HH, Konr\u00e1dsd\u00f3ttir F, et al. Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations. Pharmazie. 2008;63(3):171\u2013179.","journal-title":"Pharmazie"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.07.055"},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015352"},{"key":"e_1_3_5_141_1","doi-asserted-by":"crossref","unstructured":"Curcio CA Johnson M. Chapter 20 - structure function and pathology of Bruch\u2019s membrane. In: Ryan S Sadda S Hinton D et al. editors. Retina. 4th ed. London: W.B. Saunders; 2013. p. 465\u2013481.","DOI":"10.1016\/B978-1-4557-0737-9.00020-5"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2012.04.005"},{"key":"e_1_3_5_143_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.4.3.11"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-010-9183-3"},{"key":"e_1_3_5_145_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12030269"},{"key":"e_1_3_5_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2023.109697"},{"key":"e_1_3_5_147_1","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2022.954771"},{"key":"e_1_3_5_148_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-016-0339-2"},{"key":"e_1_3_5_149_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42104-2"},{"key":"e_1_3_5_150_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-016-0319-4"},{"issue":"9","key":"e_1_3_5_151_1","first-page":"1893","article-title":"Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning","volume":"36","author":"Olsen TW","year":"1995","unstructured":"Olsen TW, Edelhauser HF, Lim JI, et al. Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning. Invest Ophthalmol Visual Sci. 1995;36(9):1893\u20131903.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2010.08.028"},{"issue":"5","key":"e_1_3_5_153_1","first-page":"1181","article-title":"Diffusion of high molecular weight compounds through sclera","volume":"41","author":"Ambati J","year":"2000","unstructured":"Ambati J, Canakis CS, Miller JW, et al. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Visual Sci. 2000;41(5):1181\u20131185.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_5_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4835(85)90138-1"},{"issue":"5","key":"e_1_3_5_155_1","first-page":"1186","article-title":"Transscleral delivery of bioactive protein to the choroid and retina","volume":"41","author":"Ambati J","year":"2000","unstructured":"Ambati J, Gragoudas ES, Miller JW, et al. Transscleral delivery of bioactive protein to the choroid and retina. Invest Ophthalmol Visual Sci. 2000;41(5):1186\u20131191.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_5_156_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-1051"},{"key":"e_1_3_5_157_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0304782"},{"key":"e_1_3_5_158_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2328"},{"key":"e_1_3_5_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2011.11.011"},{"key":"e_1_3_5_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2016.12.001"},{"key":"e_1_3_5_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2010.12.004"},{"key":"e_1_3_5_162_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-021-09774-9"},{"key":"e_1_3_5_163_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2014.883411"},{"key":"e_1_3_5_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2015.05.003"},{"key":"e_1_3_5_165_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11080365"},{"key":"e_1_3_5_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2013.01.018"},{"key":"e_1_3_5_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2020.08.019"},{"key":"e_1_3_5_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2005.03.010"},{"key":"e_1_3_5_169_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-9920-7_6"},{"key":"e_1_3_5_170_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007517912927"},{"key":"e_1_3_5_171_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.5b00900"},{"key":"e_1_3_5_172_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3305-1_12"},{"key":"e_1_3_5_173_1","doi-asserted-by":"publisher","DOI":"10.1089\/108076801753162807"},{"key":"e_1_3_5_174_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2018.07.034"},{"key":"e_1_3_5_175_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-008-9728-7"},{"key":"e_1_3_5_176_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(01)00018-0"},{"key":"e_1_3_5_177_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79377-w"},{"key":"e_1_3_5_178_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2013.107"},{"key":"e_1_3_5_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2022.05.008"},{"key":"e_1_3_5_180_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061253"},{"key":"e_1_3_5_181_1","volume-title":"Ovalbumin as a model protein for ranibizumab in a poly(lactic-co-glycolic) acid microsphere drug delivery system","author":"Osswald C","year":"2014","unstructured":"Osswald C, Kang-Mieler JJ. Ovalbumin as a model protein for ranibizumab in a poly(lactic-co-glycolic) acid microsphere drug delivery system. Invest Ophthalmol Vis Sci. 2014;55(13):464."},{"key":"e_1_3_5_182_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtnano.2022.100264"},{"key":"e_1_3_5_183_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2012.01.019"},{"key":"e_1_3_5_184_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121725"},{"key":"e_1_3_5_185_1","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.12"},{"issue":"6","key":"e_1_3_5_186_1","first-page":"433","article-title":"Injectable depot forming thermoresponsive hydrogel for sustained intrascleral delivery of Sunitinib using hollow microneedles","volume":"38","author":"Gade SS","year":"2022","unstructured":"Gade SS, Pentlavalli S, Mishra D, et al. Injectable depot forming thermoresponsive hydrogel for sustained intrascleral delivery of Sunitinib using hollow microneedles. J Ocul Pharmacol Ther. 2022;38(6):433\u2013448.","journal-title":"J Ocul Pharmacol Ther"},{"key":"e_1_3_5_187_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.01.051"},{"key":"e_1_3_5_188_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c04494"},{"key":"e_1_3_5_189_1","doi-asserted-by":"publisher","DOI":"10.1089\/adt.2019.920"},{"key":"e_1_3_5_190_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S295223"},{"key":"e_1_3_5_191_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2022.02.019"},{"key":"e_1_3_5_192_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S316564"},{"key":"e_1_3_5_193_1","doi-asserted-by":"publisher","DOI":"10.2174\/1567201815666181017095708"},{"key":"e_1_3_5_194_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2016.06.025"},{"key":"e_1_3_5_195_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-022-02287-3"},{"key":"e_1_3_5_196_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)60847-1"},{"key":"e_1_3_5_197_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2013.5002"},{"key":"e_1_3_5_198_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2019.02.001"},{"key":"e_1_3_5_199_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13502"},{"key":"e_1_3_5_200_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.08.058"},{"key":"e_1_3_5_201_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.8b00620"},{"key":"e_1_3_5_202_1","doi-asserted-by":"publisher","DOI":"10.1021\/nn506599f"},{"key":"e_1_3_5_203_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-020-01877-9"},{"key":"e_1_3_5_204_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15102419"},{"key":"e_1_3_5_205_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.04.041"},{"key":"e_1_3_5_206_1","doi-asserted-by":"publisher","DOI":"10.5920\/bjpharm.1174"},{"key":"e_1_3_5_207_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2020.10.028"},{"key":"e_1_3_5_208_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-020-00745-9"},{"key":"e_1_3_5_209_1","doi-asserted-by":"publisher","DOI":"10.3390\/scipharm88030030"},{"key":"e_1_3_5_210_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2015.02.011"},{"key":"e_1_3_5_211_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.01.001"},{"issue":"8","key":"e_1_3_5_212_1","first-page":"4115","article-title":"Modifications of Sunitinib-loaded GB-102 microparticles that lengthen drug release: 9-months ocular tolerability and PK in rabbit following IVT dosing","volume":"58","author":"Yang M","year":"2017","unstructured":"Yang M, Peterson W, Yu Y, et al. Modifications of Sunitinib-loaded GB-102 microparticles that lengthen drug release: 9-months ocular tolerability and PK in rabbit following IVT dosing. Invest Ophthalmol Visual Sci. 2017;58(8):4115\u20134115.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_5_213_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S231913"},{"key":"e_1_3_5_214_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.111151"},{"key":"e_1_3_5_215_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.09.036"},{"key":"e_1_3_5_216_1","doi-asserted-by":"publisher","DOI":"10.3390\/polym12112702"},{"key":"e_1_3_5_217_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.05.034"},{"key":"e_1_3_5_218_1","doi-asserted-by":"publisher","DOI":"10.3390\/gels10120781"},{"key":"e_1_3_5_219_1","doi-asserted-by":"publisher","DOI":"10.3390\/gels9070523"},{"key":"e_1_3_5_220_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.3c06804"},{"key":"e_1_3_5_221_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.124321"},{"key":"e_1_3_5_222_1","doi-asserted-by":"publisher","DOI":"10.3390\/polym15092149"},{"key":"e_1_3_5_223_1","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00228"},{"key":"e_1_3_5_224_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1474-0"},{"key":"e_1_3_5_225_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2022.2092745"},{"key":"e_1_3_5_226_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16091241"},{"key":"e_1_3_5_227_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2024.2435461"},{"key":"e_1_3_5_228_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2024.100586"},{"key":"e_1_3_5_229_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000004087"},{"key":"e_1_3_5_230_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094404"},{"key":"e_1_3_5_231_1","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S52821"},{"key":"e_1_3_5_232_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1416924"},{"issue":"63","key":"e_1_3_5_233_1","first-page":"159","article-title":"Pharmacogenomics in ophthalmology","volume":"12","author":"Shastry BS","year":"2011","unstructured":"Shastry BS. Pharmacogenomics in ophthalmology. Discov Med. 2011;12(63):159\u2013167.","journal-title":"Discov Med"},{"key":"e_1_3_5_234_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.15.173"},{"key":"e_1_3_5_235_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2019-000273"},{"key":"e_1_3_5_236_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2019.04.009"},{"key":"e_1_3_5_237_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16010032"},{"key":"e_1_3_5_238_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02955-3"},{"key":"e_1_3_5_239_1","doi-asserted-by":"publisher","DOI":"10.1586\/eop.12.56"},{"key":"e_1_3_5_240_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123768"},{"key":"e_1_3_5_241_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.125099"},{"key":"e_1_3_5_242_1","doi-asserted-by":"publisher","DOI":"10.3390\/app14166980"},{"key":"e_1_3_5_243_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomimetics9120733"},{"key":"e_1_3_5_244_1","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2019.00478"},{"key":"e_1_3_5_245_1","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2024.08.19"},{"key":"e_1_3_5_246_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjo.2024.100096"},{"key":"e_1_3_5_247_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-83767-9"},{"key":"e_1_3_5_248_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38056-w"},{"key":"e_1_3_5_249_1","doi-asserted-by":"publisher","DOI":"10.3390\/mi15070856"},{"key":"e_1_3_5_250_1","doi-asserted-by":"publisher","DOI":"10.3390\/bios13100933"},{"key":"e_1_3_5_251_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba3252"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2025.2516668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:09:25Z","timestamp":1762254565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2025.2516668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":249,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"alternative-id":["10.1080\/17425247.2025.2516668"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2025.2516668","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-03-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}